quantisnow
FeedTopReportsPricing
⌘K
Live feed
13:35:51·1471d
NEWSRelease
Aeglea BioTherapeutics Inc. logo
Antares Pharma Inc. logo
Biofrontera Inc. logo
+9

12 Health Care Stocks Moving In Wednesday's Intraday Session

AGLE· Aeglea BioTherapeutics Inc.ATRS· Antares Pharma Inc.BFRI· Biofrontera Inc.BPTH· Bio-Path Holdings Inc.EXAI· Exscientia PlcFULC· Fulcrum Therapeutics Inc.
Health Care
Original source

Companies

  • AGLE
    Aeglea BioTherapeutics Inc.
    Health Care
  • ATRS
    Antares Pharma Inc.
    Health Care
  • BFRI
    Biofrontera Inc.
    Health Care
  • BPTH
    Bio-Path Holdings Inc.
    Health Care
  • EXAI
    Exscientia Plc
    Health Care
  • FULC
    Fulcrum Therapeutics Inc.
    Health Care
  • HSTO
    Histogen Inc.
    Health Care
  • KLDO
    Kaleido Biosciences Inc.
    Health Care
  • NSTG
    NanoString Technologies Inc.
    Health Care
  • PTE
    PolarityTE Inc.
    Health Care
  • SRRA
    Sierra Oncology Inc.
    Health Care
  • TPTX
    Turning Point Therapeutics Inc.
    Health Care

Recent analyst ratings

  • Jan 12FULCUpdateAnalyst$20.00
  • Nov 24FULCUpdateTruist-
  • Jul 29FULCUpdateH.C. Wainwright$12.00
  • May 23FULCUpdateLeerink Partners$12.00
  • May 15FULCUpdateCantor Fitzgerald$10.00
  • Sep 13FULCUpdateH.C. Wainwright$4.00

Related

  • PR4d
    Fulcrum Therapeutics to Host First Quarter 2026 Financial Results Conference Call and Webcast on Monday, April 27, 2026, at 8:00 a.m. ET
  • SEC28d
    Amendment: SEC Form SCHEDULE 13G/A filed by Fulcrum Therapeutics Inc.
  • SEC29d
    SEC Form 1-A filed by Bio-Path Holdings Inc.
  • SEC35d
    Bio-Path Holdings Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
  • SEC35d
    SEC Form 10-K filed by Biofrontera Inc.
  • SEC36d
    Biofrontera Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
  • PR36d
    Biofrontera Inc. Reports Record Fourth Quarter and Full Year 2025 Financial Results and Provides a Business Update
  • PR36d
    MedicAlert Foundation, Sickle Cell Disease Association of America, Inc. (SCDAA), and Fulcrum Therapeutics Partner to Accelerate Emergency Department Access to Critical Care Information for People Living with Sickle Cell Disease
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022